Gene · 6573
Papers1,999
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,999
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Radiotherapy enhances M1 macrophage immunogenic activity through IFNs induction and stimulation in TP53-wild type tumors. | Cancer Immunol Immunother | 2026 | 41653234 | PubTator, text mining | PubMed |
| Multi-omics integration in deciphering non-small cell lung cancer drug resistance: current status, challenges, and future prospects. | Hereditas | 2026 | 41622239 | PubTator, text mining | PubMed |
| SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic-transcriptional reprogramming. | Cell Death Dis | 2026 | 41620398 | PubTator, text mining | PubMed |
| MTHFR‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review). | Int J Mol Med | 2026 | 41574701 | PubTator, text mining | PubMed |
| Solute Carrier Family 19 Member 1 Mediates Acquired Bortezomib Resistance in Multiple Myeloma Through Chronic Stimulator of Interferon Genes Activation and Mitochondrial DNA Release. | Cell Biol Int | 2026 | 41556422 | PubTator, text mining | PubMed |
| One‑carbon pathway gene expression analyses in blood samples of subjects with trisomy 21. | Clin Chim Acta | 2026 | 41318080 | PubTator, text mining | PubMed |
| Mass spectrometry in ocular drug research. | Mass Spectrom Rev | 2026 | 37530668 | PubTator, text mining | PubMed |
| Genetic Markers of Methotrexate Treatment Failure in Psoriasis. | J Pers Med | 2025 | 41590498 | PubTator, text mining | PubMed |
| DNA mismatch repair mediated by Mlh1-Pms1 endonuclease-catalyzed mispair excision. | Proc Natl Acad Sci U S A | 2025 | 41439704 | PubTator, text mining | PubMed |
| Identification of locally advanced rectal cancer-related genes based on transcriptome and mendelian randomization analysis with biological validation. | Front Immunol | 2025 | 41376620 | PubTator, text mining | PubMed |
| Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland. | Sci Rep | 2025 | 41298791 | PubTator, text mining | PubMed |
| Integrating functional genomics and proteomics identifies Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in T-cell lymphoma. | bioRxiv | 2025 | 41279001 | PubTator, text mining | PubMed |
| Pharmacogenetic insights into MTHFR and SLC19A1 variants in low-dose methotrexate therapy for rheumatologic diseases. | Drug Metab Pers Ther | 2025 | 41259404 | PubTator, text mining | PubMed |
| Lactylation-related multigene signature in multiple myeloma: integrated prognostic stratification, immune landscape profiling, and therapeutic guidance. | Immunol Res | 2025 | 41205015 | PubTator, text mining | PubMed |
| Methotrexate gene polymorphisms link to toxicity but not pharmacokinetics in Chinese adults and adolescents with acute lymphoblastic leukemia. | Drug Metab Dispos | 2025 | 41175506 | PubTator, text mining | PubMed |
| Mechanism of trinucleotide repeat expansion by MutSβ-MutLγ and contraction by FAN1. | Nat Commun | 2025 | 41145416 | PubTator, text mining | PubMed |
| DNA2 and MSH2 cooperatively repair stabilized G4 and allow efficient telomere replication. | Nat Commun | 2025 | 41006252 | PubTator, text mining | PubMed |
| Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors. | Drug Metab Dispos | 2025 | 40816224 | PubTator, text mining | PubMed |
| A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. | Ann Med | 2025 | 40742006 | PubTator, text mining | PubMed |
| The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment. | Biochem Biophys Rep | 2025 | 40734997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6573/papers?page=2